13D Filings
MediWound Ltd.
MDWD
Amendment
Ownership

11.56%

Total Shares

1,481,521

Issuer CIK

1593984

CUSIP

M68830112

Event Date

Sep 29, 2025

Accepted

Oct 3, 2025, 09:30 PM

Reporting Persons (7)
Joint Filing

This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.

NameType% of ClassAggregateSole VotingShared Voting
Clal Industries Ltd.
CO
11.56%1,481,52101,481,521
Access Industries, LLC
Other
11.56%1,481,52101,481,521
Access Industries Management, LLC
Other
11.56%1,481,52101,481,521
Access Industries Holdings LLC
Other
11.56%1,481,52101,481,521
Clal Biotechnology Industries Ltd.
CO
11.56%1,481,521308,8111,172,710
Len Blavatnik
Individual
11.56%1,481,52101,481,521
Clal Life Sciences L.P.
Partnership
9.15%1,172,7101,172,7100
Disclosure Items (3)

Security Title

Ordinary Shares, par value NIS 0.07 per share

Issuer Name

MediWound Ltd.

Issuer Address

42 Hayarkon Street, Yavne, L3, 8122745

Percentage of Class

Items 5(a) and (b) to the Schedule are hereby amended and restated as follows: (a) and (b) The responses of each of the Reporting Persons with respect to Rows 11, 12, and 13 of the cover pages of this Schedule 13D that relate to the aggregate number and percentage of ordinary shares, par value NIS 0.07 per share (the "Ordinary Shares") (including but not limited to footnotes to such information) are incorporated herein by reference.

Number of Shares

The responses of each of the Reporting Persons with respect to Rows 7, 8, 9, and 10 of the cover pages of this Schedule 13D that relate to the number of Ordinary Shares as to which each of the persons or entities referenced in Item 2 above has sole or shared power to vote or to direct the vote of and sole or shared power to dispose of or to direct the disposition of (including but not limited to footnotes to such information) are incorporated herein by reference.

Shareholders

CBI owns directly 308,811 Ordinary Shares, and may be deemed to share voting and investment power over the 1,172,710 Ordinary Shares owned directly by CLS, the general partner of which, Clal Application Center Ltd., is wholly owned by CBI. CBI is a publicly traded company traded on the Tel Aviv Stock Exchange. Each of AIH, Access LLC, AIM, Clal Industries and Mr. Blavatnik may be deemed to share voting and investment power over the Ordinary Shares owned directly by CBI and CLS because (i) Len Blavatnik controls AIM, AIH, Access LLC and AI International GP Limited (the general partner of AI SMS, as defined below), (ii) AIM controls Access LLC and AIH, (iii) Access LLC controls a majority of the outstanding voting interests in AIH, (iv) AIH owns a majority of the equity of AI SMS L.P. ("AI SMS"), (v) AI SMS controls AI Diversified Holdings Ltd. ("Holdings Limited"), (vi) Holdings Limited owns AI Diversified Parent S.a r.l., which owns AI Diversified Holdings S.a r.l., which owns Access AI Ltd ("Access AI"), (vii) Access AI wholly owns Clal Industries, (viii) Clal Industries is the controlling shareholder of CBI, and (ix) CBI is the sole shareholder of Clal Application Center Ltd. The Reporting Persons, other than CBI and CLS, and each of their affiliated entities and the officers, partners, members and managers thereof, disclaims beneficial ownership of these securities.

Exhibit 99.3 Joint Filing Agreement (incorporated by reference to Exhibit 99.2 to Schedule 13D/A filed with the SEC on September 1, 2023).